The Francis Crick Institute
Browse

The future of machine learning within target identification: Causality, reversibility, and druggability

Download (96.1 kB)
journal contribution
posted on 2024-03-21, 10:23 authored by Jake P Taylor‐King, Michael Bronstein, David Roblin
To increase the rate of success within the drug development pipeline, the most effective strategy would be to improve the choice of nominated targets at the preclinical stages. Ironically, this is where machine learning has had only a modest application within biomedical science. Here, we outline an emerging strategy, advocated for by ourselves and others, leveraging diverse datasets and experiments across population and functional genetics, single cell technologies, and structural biology.

History

Usage metrics

    The Francis Crick Institute

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC